Cazenave JP - Search Results

1

Hemostatic changes in human adoptive immunotherapy with activated blood monocytes or derived macrophages.

Wiesel ML, Faradji A, Grunebaum L, Bohbot A, Schmitt-Goguel M, Bergerat JP, Cazenave JP, Oberling F. Wiesel ML, et al. Among authors: cazenave jp. Ann Hematol. 1992 Aug;65(2):75-8. doi: 10.1007/BF01698133. Ann Hematol. 1992. PMID: 1324742 Clinical Trial.

2

[Variations of plasma Willebrand factor and fibrinogen in coronary pathology].

Wiesel ML, Mossard JM, Grunebaum L, Cazenave JP, Sacrez A. Wiesel ML, et al. Among authors: cazenave jp. Ann Biol Clin (Paris). 1992;50(1):15-9. Ann Biol Clin (Paris). 1992. PMID: 1443785 French.

3

[Congenital deficiencies of natural anticoagulant systems responsible for recurrent thromboembolism].

Grunebaum L, Wiesel ML, Freyssinet JM, Cazenave JP. Grunebaum L, et al. Among authors: cazenave jp. Rev Med Interne. 1991 Jan-Feb;12(1):37-41. doi: 10.1016/s0248-8663(05)81351-7. Rev Med Interne. 1991. PMID: 1828303 French.

4

Screening of protein S deficiency using a functional assay in patients with venous and arterial thrombosis.

Wiesel ML, Charmantier JL, Freyssinet JM, Grunebaum L, Schuhler S, Cazenave JP. Wiesel ML, et al. Among authors: cazenave jp. Thromb Res. 1990 Jun 1;58(5):461-8. doi: 10.1016/0049-3848(91)90251-q. Thromb Res. 1990. PMID: 2142342

5

[Antiphospholipid antibodies (aPL): detection and clinical significance].

Grunebaum L, Kheiralla JC, Wiesel ML, Freyssinet JM, Goetz J, Imler M, Cazenave JP. Grunebaum L, et al. Among authors: cazenave jp. Rev Med Interne. 1992 Jul-Aug;13(4):307-14. doi: 10.1016/s0248-8663(05)80309-1. Rev Med Interne. 1992. PMID: 1287776 Review. French.

6

[Protein C: importance of its assay in pathology].

Wiesel ML, Grunebaum L, Freyssinet JM, Cazenave JP. Wiesel ML, et al. Among authors: cazenave jp. Presse Med. 1988 Jul 2;17(26):1333-4, 1337. Presse Med. 1988. PMID: 2970077 French. No abstract available.

7

[Comparative thrombotic risk of two contrast agents in coronary angiography].

Wolff F, Zupan M, Klero de Rosbo P, Wiesel ML, Grunebaum L, Cazenave JP, Brechenmacher C. Wolff F, et al. Among authors: cazenave jp. Ann Radiol (Paris). 1994;37(6):435-9. Ann Radiol (Paris). 1994. PMID: 7702336 Clinical Trial. French.

8

Prevalence and significance of anticardiolipin antibodies in Crohn's disease.

Chamouard P, Grunebaum L, Wiesel ML, Freyssinet JM, Duclos B, Cazenave JP, Baumann R. Chamouard P, et al. Among authors: cazenave jp. Dig Dis Sci. 1994 Jul;39(7):1501-4. doi: 10.1007/BF02088055. Dig Dis Sci. 1994. PMID: 8026262

9

Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.

Chamouard P, Grunebaum L, Wiesel ML, Frey PL, Wittersheim C, Sapin R, Baumann R, Cazenave JP. Chamouard P, et al. Among authors: cazenave jp. Eur J Gastroenterol Hepatol. 1995 Dec;7(12):1183-8. doi: 10.1097/00042737-199512000-00010. Eur J Gastroenterol Hepatol. 1995. PMID: 8789309

10

The treatment of deep vein thrombosis with continuous intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study.

Kretz JG, Chakfe N, Wiesel ML, Grunebaum L, Zamboni V, Palazzini E, Cazenave JP. Kretz JG, et al. Among authors: cazenave jp. Thromb Res. 1996 Dec 15;84(6):391-8. doi: 10.1016/s0049-3848(96)00207-1. Thromb Res. 1996. PMID: 8987160 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page